169 related articles for article (PubMed ID: 37978394)
21. [Clinical study of 131 children with multi-system Langerhans cell histiocytosis].
Wu FF; Gao YJ; Pan C; Chen J; Tang JY
Zhonghua Er Ke Za Zhi; 2016 May; 54(5):349-53. PubMed ID: 27143076
[TBL] [Abstract][Full Text] [Related]
22. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
Weitzman S; Braier J; Donadieu J; Egeler RM; Grois N; Ladisch S; Pötschger U; Webb D; Whitlock J; Arceci RJ
Pediatr Blood Cancer; 2009 Dec; 53(7):1271-6. PubMed ID: 19731321
[TBL] [Abstract][Full Text] [Related]
23. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
24. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kawaguchi H; Sakashita K; Yasui M; Koga Y; Kobayashi R; Ishii E; Fujimoto J; Horibe K; Bessho F; Tsunematsu Y; Imashuku S
Int J Hematol; 2016 Jul; 104(1):99-109. PubMed ID: 27040279
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and outcomes of Langerhans cell histiocytosis at a single institution in Thailand: a 20-year retrospective study.
Kitticharoenjit P; Supakul N; Rujkijyanont P; Traivaree C; Photia A; Monsereenusorn C
Asian Biomed (Res Rev News); 2021 Aug; 15(4):171-181. PubMed ID: 37551332
[TBL] [Abstract][Full Text] [Related]
26. Childhood Langerhans cell histiocytosis: a disease with many faces.
Leung AKC; Lam JM; Leong KF
World J Pediatr; 2019 Dec; 15(6):536-545. PubMed ID: 31456157
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India.
Narula G; Pradhan ND; Arora B; Banavali SD
Pediatr Blood Cancer; 2018 Aug; 65(8):e27028. PubMed ID: 29512864
[TBL] [Abstract][Full Text] [Related]
28. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
[TBL] [Abstract][Full Text] [Related]
29. Langerhans Cell Histiocytosis: Single Center Experience of 25 Years.
Tuysuz G; Yildiz I; Ozdemir N; Adaletli I; Kurugoglu S; Apak H; Dervisoglu S; Bozkurt S; Celkan T
Mediterr J Hematol Infect Dis; 2019; 11(1):e2019035. PubMed ID: 31205639
[TBL] [Abstract][Full Text] [Related]
30. Pediatric langerhans cell histiocytosis: single center experience over a 17-year period.
İnce D; Demirağ B; Özek G; Erbay A; Ortaç R; Oymak Y; Kamer S; Yaman Y; Kundak S; Vergin C
Turk J Pediatr; 2016; 58(4):349-355. PubMed ID: 28276205
[TBL] [Abstract][Full Text] [Related]
31. Exploration of treatment in childhood Langerhans cell histiocytosis based on inflammatory and malignant symptoms: a pilot study.
Lin HL; Zheng QQ; Huang RL; Hu R; Liu XD; Wang JY
Orphanet J Rare Dis; 2024 Apr; 19(1):174. PubMed ID: 38654381
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcomes of childhood Langerhans cell histiocytosis in Taiwan: A single-center, 20-year experience.
Wang DS; Lu MY; Yang YL; Lin DT; Lin KH; Chang HH; Jou ST
J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):594-601. PubMed ID: 32741735
[TBL] [Abstract][Full Text] [Related]
33. Vulvar Lesions in an 8-Year-Old Girl: Cutaneous Manifestations of Multisystem Langerhans Cell Histiocytosis.
Jorgensen EM; Chen PP; Rutter S; Cron JA
J Pediatr Adolesc Gynecol; 2018 Apr; 31(2):153-155. PubMed ID: 28993226
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous Langerhans cell histiocytosis: study of Asian children shows good overall prognosis.
Ng SS; Koh MJ; Tay YK
Acta Paediatr; 2013 Nov; 102(11):e514-8. PubMed ID: 23909818
[TBL] [Abstract][Full Text] [Related]
35. Langerhans cell histiocytosis of spine: a comparative study of clinical, imaging features, and diagnosis in children, adolescents, and adults.
Huang WD; Yang XH; Wu ZP; Huang Q; Xiao JR; Yang MS; Zhou ZH; Yan WJ; Song DW; Liu TL; Jia NY
Spine J; 2013 Sep; 13(9):1108-17. PubMed ID: 23602327
[TBL] [Abstract][Full Text] [Related]
36. Differentiating skin-limited and multisystem Langerhans cell histiocytosis.
Simko SJ; Garmezy B; Abhyankar H; Lupo PJ; Chakraborty R; Lim KP; Shih A; Hicks MJ; Wright TS; Levy ML; McClain KL; Allen CE
J Pediatr; 2014 Nov; 165(5):990-6. PubMed ID: 25441388
[TBL] [Abstract][Full Text] [Related]
37. Discrepancies between F-18-FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis.
Ferrell J; Sharp S; Kumar A; Jordan M; Picarsic J; Nelson A
Pediatr Blood Cancer; 2021 Apr; 68(4):e28891. PubMed ID: 33442960
[TBL] [Abstract][Full Text] [Related]
38. High risk Langerhans cell histiocytosis in children: the role of salvage in improving the outcome. A single center experience.
Sedky MSM; Hamoda A; Taha H; Zaky I; Hassanain O; ElHaddad A
Orphanet J Rare Dis; 2024 Jun; 19(1):242. PubMed ID: 38910253
[TBL] [Abstract][Full Text] [Related]
39. Clinical features and treatment outcomes of Langerhans cell histiocytosis of the spine.
Xu X; Han S; Jiang L; Yang S; Liu X; Yuan H; Wei F; Wu F; Dang L; Zhou H; Zhang H; Liu Z
Spine J; 2018 Oct; 18(10):1755-1762. PubMed ID: 29505854
[TBL] [Abstract][Full Text] [Related]
40. Clinical Analysis of 122 Cases of Langerhans Cell Histiocytosis.
Wang T; Su B; Han D; Tong A; Li J; Liu Y; Jin H; Fang K
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Apr; 39(2):206-210. PubMed ID: 28483018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
